North America Malaria Treatment Market – Industry Trends and Forecast to 2030

North America Malaria Treatment Market, By Agent (Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae and P. Knowlelsi), Type (Medication and Vaccination), Treatment Type (Suppressive Treatment and Radical Treatment), Drug Type (Branded and Generics), Route of Administration (Oral and Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) – Industry Trends and Forecast to 2030.

North America Malaria Treatment Market Analysis and Size

The malaria treatment market is growing because of the high incidence of malaria and numerous malaria elimination programs by numerous international and national organizations. About 2,000 cases of malaria are diagnosed in the U.S. each year. Over the past few decades, the average number of malaria cases reported to the CDC has steadily increased. The major market players are primarily focusing on the expansion of their market presence, and the wide acquisition of new customer pool, therefore boosting business opportunities of the market.  

Data Bridge Market Research analyses a growth rate in the malaria treatment market in the forecast period 2023-2030. The expected CAGR of malaria treatment market is tend to be around 3.2% in the mentioned forecast period. The market value is USD 61.03 million in 2022, and it would grow upto USD 78.51 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Malaria Treatment Market Scope and Segmentation

Market Definition

Malaria is a kind of deadly infectious disease that is caused by the Plasmodium parasite. The varied medication categories for malaria treatment include primaquine, mefloquine, quinine, chloroquine, hydroxychloroquine, non-artemisinin based combinations (non-acts), artemisinin-based combination therapy (ACT), and others. The incidence of a wide range of malaria treatment products will offer a better patient experience and reduce the risk of death.  

North America Malaria Treatment Market Dynamics

Drivers

• Rising Prevalence of Malaria

Since the past few decades, the reports of CDC states that the average number of malaria cases has steadily increased. Based on the most recent and available annual malaria surveillance reports (2011, 2012, 2014–2016), an average of 1773 malaria cases are recorded in the U.S. each year. In 2016, a total of 2078 cases were witnessed, the highest number of malaria cases since 1972. Around 2,000 cases of malaria are diagnosed in the U.S. each year. Apart from this, the increasing number of traveler malaria cases is also increasing the demand for the malaria treatment modalities, as every year, thousands of people travel to the malaria-affected region. Thus, this boost the growth of the treatment market.

• Increasing Demand of Direct Tender Channel

The direct tender segment is increasing the malaria treatment market since direct tender holds the largest market share combined with the highest CAGR. It is mostly because of the service providers who buy the product from numerous manufacturers and it is observed that the revenue from direct sales is more beneficial in the malaria treatment market.

Opportunities

• Increasing Diagnostic Tests For Malaria

Numerous companies are manufacturing rapid diagnostic tests with high sensitivity. For instance, several researchers from Rice University came up with a simple microneedle patch similar to a bandage to detect malaria, to minimize the huge burden of disease in countries struggling with poor health infrastructure in November 2020. The microneedles in the patch collect interstitial fluid which contain few biomarkers that aids in detecting malaria. Thus, this boost the market growth.

• Growing Strategic Alliances and Agreements

There have been increasing alliances and agreements between organizations that cause immense growth in the market. For instance, ADVANZ PHARMA Corp. Limited acquired Correvio Pharma Corp which is a specialty pharmaceutical company in May 2020. The acquisition provided ADVANZ PHARMA with an immediate and direct commercial presence in Germany, Italy, France, Spain, and the Benelux region.

Restraints/Challenges

• Developing Quality Issues of Drugs

Numerous quality issues related with malaria drug preparations are also projected to impede growth of the market. Numerous manufacturers are not obtaining WHO prequalification for manufacturing malaria treatment drugs, which leads to the increased production of deteriorated quality drugs in the market.

This malaria treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the malaria treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on North America Malaria Treatment Market

The COVID-19 outbreak has increased the demand for numerous anti-malarial medications, North Americaly, supporting to the growth of malaria treatment market. For instance, on March 30, 2020, US FDA, issued an emergency use authorization (EUA) that enables the use of hydroxychloroquine and chloroquine products which is widely used for the treatment of adolescent and adult patients with COVID-19 who have been hospitalized. In 2018, Bayer AG donated 3 million tablets of its chloroquine phosphate formulation, Resochin, that showed potential for treating the coronavirus infection. Such types of government and companies’ initiatives are playing a major role in the growth the malaria treatment market.

Recent Developments

• In 2021, Zydus Cadila announced the plan for the antimalarial drug ZY19489 with Medicines For Malaria Venture which received U.S.FDA Approval. The company stated that the Phase I study of ZY19489 has shown a long half-life and potential for a single-dose cure for malaria. In a separate malaria challenge trial, potent antimalarial activity has been shown post single-dose oral administration of ZY19489.

North America Malaria Treatment Market Scope

The malaria treatment market is segmented on the basis of agent, type, treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Agent

• Plasmodium Falciparum
• P. Vivax
• P. Ovale
• P. Malariae
• P. Knowlelsi

Type

• Medication
• Vaccination

Treatment Type

• Suppressive Treatment
• Radical Treatment

Route of Administration

• Oral
• Parenteral

End User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others

Distribution Channel

• Direct Tender
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Malaria Treatment Market Regional Analysis/Insights

The malaria treatment market is analyzed and market size insights and trends are provided by agent, type, treatment type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the malaria treatment market report are U.S., Canada and Mexico in North America.

Germany is leading the market because of the enormous incidence of malaria vector-borne disease. The rising funding from regional governments, increased clinical developments and product launches are combines severely impacting the market growth positively.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and North America Malaria Treatment Market Share Analysis

The malaria treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to malaria treatment market.

Key players operating in the malaria treatment market include:

• Actiza Pharmaceutical Private Limited (India)
• Amneal Pharmaceuticals LLC. (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Cipla Inc. (India)
• Lupin (India)
• Ipca Laboratories Ltd (India)
• Mylan N.V. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Zydus Group (India)
• MMV (Switzerland)
• Novartis AG (Switzerland)
• Sumaya Biotech (Germany)
• Taj Pharmaceuticals Limited (India)
• OSIVAX (France)
• Strides Pharma Science Limited (India)